Nuwellis, Inc. (NUWE) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Nuwellis, Inc. in 2026. The next earnings report is expected on November 17, 2026.
Next earnings date
17 Nov 2026
In 89 days
EPS estimate
-13.65
Revenue estimate
2.5M
Past earnings
Latest earnings analysis
Nuwellis, Inc. missed consensus estimates in its latest earnings report, with EPS of -$26.64 falling short of the -$23.80 estimate and revenue of $1.97 million coming in 18.5% below expectations. In the prior quarter EPS also missed expectations while revenue came in ahead of estimates.
No dividend history available.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc. (NUWE) is scheduled to report earnings on November 17, 2026.
Nuwellis, Inc. (NUWE) last reported earnings on August 13, 2026.
Nuwellis, Inc. (NUWE) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.